Skip to main content
Clinical Trials/KCT0000585
KCT0000585
Recruiting
未知

Dexmedetomidine as a premedication to reduce emergence agitation and pain in adults after closed reduction of nasal bone fracture

Myongji Hospital0 sites116 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Injury, poisoning and certain other consequences of external causes
Sponsor
Myongji Hospital
Enrollment
116
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patients classified as American Society of Anesthesiologists physical status 1 or 2 who are scheduled undergoing elective closed reduction for nasal bone fracture

Exclusion Criteria

  • known allergies fo dexmedetomidine, medication of beta blocking agent,medication of alpha blocking agent, renal disease, hepatic dysfunction, signs of preoerative upper respiratory tract infection, diagnosed obstructive sleep apnea, diagnosed neuropsycholodical disease

Outcomes

Primary Outcomes

Not specified

Similar Trials